BusinessHitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution RightsBy Nasdaq OMXApr 12, 2018, 1:00 PM UTC
BusinessRich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML PatientsBy Nasdaq OMXApr 10, 2018, 11:01 AM UTC
BusinessGalectin Therapeutics to Present at H.C. Wainwright Global Life Sciences ConferenceBy Nasdaq OMXApr 2, 2018, 2:20 PM UTC
BusinessKarmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non-Hodgkin LymphomaBy Nasdaq OMXMar 27, 2018, 12:05 PM UTC
BusinessINmune Bio’s Professor Mark Lowdell to Participate as Expert Speaker at the Third Annual Innate Killer Summit 2018By Nasdaq OMXMar 26, 2018, 12:30 PM UTC
BusinesseFFECTOR Announces Appointment of John W. Smither to its Board of DirectorsBy Nasdaq OMXMar 23, 2018, 6:00 PM UTC
BusinessCBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 AntibodyBy Nasdaq OMXMar 22, 2018, 1:34 PM UTC
BusinessTodos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, IsraelBy Nasdaq OMXMar 22, 2018, 12:00 PM UTC
